Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 2, 1998, Pages 285-288

  Evans, Martin E ^a   Titlow, William B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; GENOTYPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; STAPHYLOCOCCUS AUREUS;

EID: 0031917612     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.2.285     Document Type: Article

References (9)

1. Chin, N.-X. & Neu, H. C. (1984). Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 25,319-26.
2. Peterson, L R., Quick, J. N., Jensen, B., Homann, S., Johnson, S., Tenquist, J. état. (1990). Emergence of Ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during Ciprofloxacin plus rifampin therapy for methicillinresistant S. aureus colonization. Archives of Internal Medicine 150, 2151-5.
3. Mulligan, M. E., Ruane, P. J., Johnston, L, Wong, P., Wheelock, J. P., Macdonald, K. et al. (1987). Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. American Journal of Medicine 82,215-9.
4. Daum, T. E., Schaberg, D. R., Terpenning, M. S., Sottile, W. S. & Kauffman, C. A. (1990). Increasing resistance of Staphylococcus aureus to Ciprofloxacin. Antimicrobial Agents and Chemotherapy 34,1862-3.
5. Forstall, G. J., Knapp, C. C. & Washington, J. A. (1991). Activity of new quinolones against ciprofioxacin-resistant staphylococci. Antimicrobial Agents and Chemotherapy 35,1679-81.
6. Kaatz, G. W., Seo, S. M., Barriere, S. L, Albrecht, L. M. & Rybak, M. J. (1990). Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 34, 257-60.
7. Kang, S. L, Rybak, M. J., McGrath, B. J., Kaatz, G. W. & Seo, S. M. (1994). Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin against methicillin-susceptible and -resistant Staphylococcus aureus in an in-vitro infection model. Antimicrobial Agents and Chemotherapy 38,2702-9.
8. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobicatly-Fourth Edition; Approved Standard M7-A4. NCCLS, Villanova, PA.
9. Struelens, M. J., Deplano, A., Godard, C., Maes, N. & Serruys, E. (1992). Epidemiologie typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis. Journal of Clinical Microbiology 30,2599-605. j